FREDERICK, Md. — RoosterBio Inc., a privately held regenerative medicine manufacturing platform technology company, has announced plans to expand in Frederick after a year of rapid growth.
Founded in 2013, RoosterBio Inc. launched operations inside of the Frederick Innovative Technology Center Inc. incubator with five people. In February 2018, the company held a ribbon cutting for its custom-built, 14,000-square-foot facility designed to accommodate innovation in scale-up of mesenchymal cell manufacturing, research and development. In January, the company grew to more than 40 employees and plans to double again in the next 18 to 24 months.
RoosterBio has been shaping the new field of regenerative medicine manufacturing.